Frequency and clinical significance of chromosomal inversions prenatally diagnosed by second trimester amniocentesis

• Published in: Scientific reports 2022-02, Vol.12 (1), p.2215-2215, Article 2215
• Main Authors: Chien, Chih-Wei, Chao, An-Shine, Chang, Yao-Lung, Chen, Kuan-Ju, Peng, Hsiu-Huei, Lin, Yu-Ting, Chao, Angel, Chang, Shuenn-Dyh
• Format: Article
• Language: English
• Subjects: 692/308; 692/4017; Amniocentesis; Aneuploidy; Asians - genetics; Birth; Birth defects; Central nervous system; Chromosome 9; Chromosome Inversion - statistics & numerical data; Chromosomes; Clinical significance; Congenital Abnormalities - diagnosis; Congenital Abnormalities - epidemiology; Congenital Abnormalities - genetics; Databases, Genetic; Female; Fetal Development - genetics; Fetuses; Founder effect; Genetic analysis; Humanities and Social Sciences; Humans; Male; multidisciplinary; Mutation; Pregnancy; Pregnancy Outcome - epidemiology; Pregnancy Outcome - genetics; Pregnancy Trimester, Second - genetics; Prenatal diagnosis; Prenatal Diagnosis - statistics & numerical data; Retrospective Studies; Science; Science (multidisciplinary); Thalassemia
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-022-06024-x

To compare the frequency and clinical significance of familial and de novo chromosomal inversions during prenatal diagnosis. This was a retrospective study of inversions diagnosed prenatally in an Asian population by applying conventional GTG-banding to amniocyte cultures. Data from 2005 to 2019 were extracted from a single-center laboratory database. The types, frequencies, and inheritance patterns of multiple inversions were analyzed. Pericentric variant inversions of chromosome 9 or Y were excluded. In total, 56 (0.27%) fetuses with inversions were identified in the 15-year database of 21,120 confirmative diagnostic procedures. Pericentric and paracentric inversions accounted for 62.5% (35/56) and 37.5% of the inversions, respectively. Familial inversions accounted for nearly 90% of cases, and de novo mutation was identified in two pericentric and two paracentric cases. Inversions were most frequently identified on chromosomes 1 and 2 (16.1% of all inversions), followed by chromosomes 6, 7, and 10 (8.9% of all cases). The indications for invasive testing were as follows: advanced maternal age (67.3%), abnormal ultrasound findings (2.1%), abnormal serum aneuploidy screening (20.4%), and other indications (10.2%). The mode of inheritance was available for 67.9% of cases (38/56), with 89.5% of inversions being inherited (34/38). A slight preponderance of inheritance in female fetuses was observed. Three patients with inherited inversions opted for termination (two had severe central nervous system lesions and one had thalassemia major). Gestation continued for 53 fetuses, who exhibited no structural defects at birth or significant developmental problems a year after birth. Our study indicates that approximately 90% of prenatally diagnosed inversions involve familial inheritance, are spreading, and behave like founder effect mutations in this isolated population on an island. This finding can help to alleviate anxiety during prenatal counseling, which further underscores the importance of parental chromosomal analysis, further genetic studies, and appropriate counseling in cases where a nonfamilial inversion is diagnosed.